SinoFresh Healthcare, Inc. Announces Execution on New Strategic Plan
Venice, Florida – FEBRUARY 15, 2011 – SinoFresh® HealthCare, Inc., (PINKSHEETS: SFSH.PK) announced today that its Board of Directors and Senior Management Team have developed and begun implementation on a 4 point strategic growth plan, incorporating the following components:
- Retained a reputable external accounting firm to audit and prepare complete financial filings to make SFSH a fully transparent reporting company under SEC guidelines .
- Complete current discussions with investment bankers to finalize arrangements to secure near and long term financing.
- Complete hiring of national wholesale sales team to implement the company’s national sales and marketing plan.
- Continue R&D programs to bring additional innovative effective products to market.
David R. Olund, CEO states, “We are very pleased to inform our shareholders of the company’s continued progress as we further implement our plans to become a fully transparent and significant player in the pharmaceutical industry. In the coming days and weeks we will continue to announce our progress as we execute on our strategic plans. We are dedicated to continuing to grow our company through product excellence and innovation to build long term profitability and significant shareholder value.”
###
SinoFresh HealthCare, Inc. is a publicly traded company (PINKSHEETS:SFSH.PK) based in Venice, Florida, that manufactures and distributes nasal, oral and topical antiseptic germ-killing products. SinoFresh products are marketed and distributed globally through a network of strategic wholesale and retail partners. SinoFresh Healthcare, Inc’s, premier product, SinoFresh Antiseptic Homeopathic Nasal spray has in laboratory tests shown effective antiseptic capability against a variety of pathogens such as MRSA, E-Coli, H1N1 and a broad range of other viruses, molds, fungi and bacteria.
This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Our forward-looking statements express our current expectations or forecasts of possible future results or events, including projections of future performance, statements of management’s plans and objectives, future contracts, and forecasts of trends and other matters. Forward-looking statements speak only as of the date of this filing, and we undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur. You can identify these statements by the fact that they do not relate strictly to historic or current facts and often use words such as “anticipate”, “estimate”, “expect”, “believe”, “will likely result”, “outlook”, “project” and other words and expressions of similar meaning. No assurance can be given that the results in any forward-looking statements will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.
Contact:
SinoFresh HealthCare Inc.
Investor Relations
941.375.8174 option 8
Tags: